| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/13/2024 | $5.00 → $3.50 | Buy → Neutral | ROTH MKM |
ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
4 - CareCloud, Inc. (0001582982) (Issuer)
8-K - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
10-Q - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
8-K - CareCloud, Inc. (0001582982) (Filer)
EFFECT - CareCloud, Inc. (0001582982) (Filer)
S-3 - CareCloud, Inc. (0001582982) (Filer)
DEFA14A - CareCloud, Inc. (0001582982) (Filer)
DEF 14A - CareCloud, Inc. (0001582982) (Filer)
10-K/A - CareCloud, Inc. (0001582982) (Filer)
SOMERSET, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell Microcap® Index, effective at the open of U.S. markets on June 30, 2025, as part of the Russell indexes' annual reconstitution based on market capitalization, public float, and related criteria. The inclusion underscores growing recognition of CareCloud's momentum in the healthcare technology sector. During Q2, the price of the Company's common stock increased by approximately 70%. Key developments during the fir
SOMERSET, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has surpassed the accelerated filer threshold with a public float of $85.1 million as of the market close on June 30, 2025. This achievement triggers a new compliance benchmark under SEC regulations—specifically, the inclusion of an auditor attestation of the Company's Internal Control over Financial Reporting ("ICFR") in accordance with Section 404(b) of the Sarbanes-Oxley Act. "This milestone is a powerful validation of CareCloud's growth t
SOMERSET, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that its current independent registered public accounting firm may resign if an ICFR auditor attestation of the Company's Internal Control over Financial Reporting ("ICFR") under Section 404(b) of the Sarbanes-Oxley Act is required for fiscal year 2025. Our audit firm has informed the Company that it does not have the capacity to perform an ICFR attestation. Under SEC rules, the same audit firm must conduct both the financial statement audit and the
Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that its Co-Chief Executive Officers have been invited to participate in the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow," presented by Maxim Group LLC. The Healthcare IT Panel, featuring CareCloud, will take place on Tuesday, June 3, 2025, at 11:00 a.m. EDT. CareCloud will join the Healthcare IT Panel to share how artificial intelligence is transforming every facet of healthcare delivery—from clinical decision support
Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company's Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders' Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's 20
SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and generative AI solutions, today announced that Maxim Group, LLC ("Maxim Group"), a leading investment bank, securities and wealth management firm, has selected CareCloud as its "Top Healthcare IT Pick for 2025," citing the transformative potential of its artificial intelligence strategy, together with its strong financial results and renewed M&A activity. "Given its positive outlook and attractive valuation, CareCloud is positioned to be our top healthcare IT pick in 2025," said Allen Klee, CFA, Managing Director and Senior Equity Rese
SOMERSET, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud's strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustained profitability and long-term growth. Management will discuss these results and the Company's 2025 growth strategies in a live conference call today at 8:30 a.m. ET. First Quarter 2025 Financial Highlights: Revenue of $27.6 million, compared to $26.0 million in Q1 2024, an increase of 6% y
SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the "Board") has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") for May and June 2025. The following table shows the monthly dividends and associated record and payment dates: May 2025June 2025 Series A dividend per share $0.18229 $0.18229 Series
SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leading provider of healthcare technology and generative AI solutions, today announced the official launch of its AI Center of Excellence (the "AI CoE") — a major strategic initiative aimed at delivering scalable, domain-specific artificial intelligence solutions purpose-built for healthcare. "Our ground-breaking AI Center officially began operations earlier this month with an inaugural team of over 50 AI engineers, data scientists, and healthcare domain experts, marking a pivotal moment in CareCloud's journey," said Hadi Chaudhry, Co-CEO of CareCloud. "The AI Center of Excellence reflects our long
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first quarter ended March 31, 2025 before the market opens on Tuesday, May 6, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud First Quarter 2025 Results Conference Call." Investors who opt for audio-onl
Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company's Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders' Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's 20
SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management ("RevNu"), an emerging audiology-focused revenue cycle management ("RCM") company based in Westminster, California. "We've spent years building trusted relationships within the audiology community, and we couldn't be more excited to join forces with CareCloud," said Clay Gililland, founder of RevNu. "That experience has given us a deep understanding of the industry's needs—insights we're excited to
SOMERSET, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Justin Pierce as its new chief sales officer (CSO). In this role, Pierce will be responsible for driving sustainable revenue growth and enhancing CareCloud's position in the rapidly evolving healthcare landscape. Pierce brings more than two decades of experience in the healthcare technology and services industry, having held leadership positions at Azalea Health, abeo, and Ventra Health. Throughout his career, he has consistently demonstrated his ability to forge
SOMERSET, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Larry Steenvoorden as the new chief financial officer (CFO). With a distinguished career and extensive financial and strategic expertise, Steenvoorden brings valuable experience from his previous roles. Before joining CareCloud, he served as the executive vice president and CFO at Chembio Diagnostics, where he implemented strategic initiatives and improved profitability. Steenvoorden has also held CFO positions in healthcare, life science, and med-tech companies,
Bill Korn appointed chief strategy officer, Joseph DosSantos joins as chief financial officer, strengthening CareCloud's position as a leader in healthcare technology solutions. SOMERSET, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDP, CCLDO))), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today a leadership transition. Bill Korn, who has been CareCloud's chief financial officer (CFO) for 10 years, will take on a new role as chief strategy officer (CSO). The company has hired Joseph C. DosSantos, an experienced financial executive in the biotechnology sector, to fill the position of chief financial o
SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in healthcare technology and generative AI solutions, today announced that Maxim Group, LLC ("Maxim Group"), a leading investment bank, securities and wealth management firm, has selected CareCloud as its "Top Healthcare IT Pick for 2025," citing the transformative potential of its artificial intelligence strategy, together with its strong financial results and renewed M&A activity. "Given its positive outlook and attractive valuation, CareCloud is positioned to be our top healthcare IT pick in 2025," said Allen Klee, CFA, Managing Director and Senior Equity Rese
SOMERSET, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud's strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustained profitability and long-term growth. Management will discuss these results and the Company's 2025 growth strategies in a live conference call today at 8:30 a.m. ET. First Quarter 2025 Financial Highlights: Revenue of $27.6 million, compared to $26.0 million in Q1 2024, an increase of 6% y
SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the "Board") has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") for May and June 2025. The following table shows the monthly dividends and associated record and payment dates: May 2025June 2025 Series A dividend per share $0.18229 $0.18229 Series
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first quarter ended March 31, 2025 before the market opens on Tuesday, May 6, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud First Quarter 2025 Results Conference Call." Investors who opt for audio-onl
SOMERSET, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the "Board") has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") for March and April 2025. The following table shows the monthly dividends and associated record and payment dates: March 2025 April 2025 Series A dividend per share $0.1822
Returns to GAAP Profitability, Achieves Record Cash Flow, Resumes Dividends & Strengthens Balance Sheet SOMERSET, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the full year ended December 31, 2024. The Company's strategic execution and AI-driven innovation have fueled a transformational turnaround, positioning CareCloud for continued profitability and long-term growth. CareCloud's management team will discuss these results and provide insights into 2025 growth strategies in a live conference call today at 8:30 a.m. ET. Full Year 2024 Perfor
SOMERSET, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, announced today (the "Mandatory Exchange Date") that it effected the mandatory conversion (the "Conversion") of shares of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Preferred Stock"), into the Company's Common Stock, $0.001 par value per share (the "Common Stock"). "We are excited to announce this conversion, which will eliminate approximately $7 million or more in annual dividend obligations, freeing us to reinvest this ca
SOMERSET, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2024 before the market opens on Thursday, March 13, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud Fourth Quarter 2024 Results Conference Call." In
SOMERSET, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and generative AI solutions, today announced that it has transferred the funds for the January 2025 dividend payments on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock. As previously disclosed, holders of Series A Preferred Stock will receive 22.917 cents per share, while holders of Series B Preferred Stock will receive 18.229 cents per share based on a record date of January 31, 2025. These payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025. "We appreciate the continue
Accelerated Timeline Reflects Strong Financial Performance and Commitment to Shareholder Value SOMERSET, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that its Board of Directors (the "Board") has decided to resume dividend payments on its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") and Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock") earlier than previously announced based on the Company's success at accel